Executive Vice President
Institute for Clinical Pharmacodynamics
Disclosure: Institute for Clinical Pharmacodynamics, Inc. (Employee)Spero Therapeutics (Grant/Research Support)
Dr. Christopher M. Rubino is one of three principal founders and the Executive Vice President, Pharmacometrics at the Institute for Clinical Pharmacodynamics (ICPD). He is also an Adjunct Assistant Research Professor in the School of Pharmacy and Pharmaceutical Sciences at the University at Buffalo. Dr. Rubino received his BS in Pharmacy from the University of Connecticut, his PharmD from the University at Buffalo, and completed a two-year post-doctoral fellowship in pediatric pharmacology at the Women’s Hospital of Greensboro.
He has served as a resource for pharmaceutical firms during the submission of adult- and pediatric-related filings to the Food and Drug Administration and European Medicines Agency across several therapeutic areas. His experience in this area spans the full breadth of activities from designing studies in adults and children to analysis of PK-PD data from such studies and, ultimately, to presentation at regulatory and international scientific meetings. He is a member of the International Society of Pharmacometrics and the American Society for Microbiology, and also serves as a member of the Antimicrobial Agents and Chemotherapy Editorial Board. He has authored more than 100 peer-reviewed publications and has assisted in refereeing numerous industry journals, including Diagnostic Microbiology and Infectious Diseases, The Journal of Clinical Pharmacology, and the Journal of Antimicrobial Chemotherapy.